تخطي إلى التنقل الرئيسي
تخطي إلى البحث
تخطي إلى المحتوى الرئيسي
الصفحة الرئيسية
المساعدة والأسئلة الشائعة
English
עברית
العربية
الصفحة الرئيسية
الملفات الشخصية
الوحدات البحثية
نتاج البحث
الجوائز
أنشطة
البحث حسب الخبرة أو الاسم أو الانتماء
عرض الملف الشخصي الخاص بـ Scopus
רקפת שטוירמן
Dr.
Senior Lecturer / Assistant Professor
,
Department of Medicine
Senior Lecturer / Assistant Professor
,
Department of Molecular Biology
https://orcid.org/0000-0002-5055-5907
1999
2024
نتاج الأبحاث سنويًا
معاينة
بصمة
الشبكة
نتاج البحث
(31)
بصمة
تأتي تسميات الموضوعات هذه من أعمال هذا الشخص. فهما يشكلان معًا بصمة فريدة.
فرز حسب
الوزن
أبجديًا
Keyphrases
Prostate Cancer Screening
100%
Breast Cancer Susceptibility Gene 1 (BRCA1)
84%
Pathogenic Variants
80%
Ashkenazi Jews
78%
Mutation Carriers
70%
Non-carriers
63%
BRCA1, BRCA2
60%
BRCA2
60%
Colorectal Cancer
58%
Israeli
56%
Ashkenazi
51%
Jewish
43%
BRCA2 mutation
39%
Prostate-specific Antigen
39%
Whole Genome Sequencing
37%
Prostate Cancer
37%
BRCA mutation Carriers
37%
Genetic Predisposition
37%
Screening Study
34%
Lynch Syndrome
33%
Breast Cancer
33%
Prostate-specific Antigen Density
32%
Primary Immunodeficiency
32%
Ethiopian
32%
Polymorphism
32%
Psychosocial Impact
32%
Ovarian Cancer
32%
BRCA mutation
30%
Israel
30%
Germ Cells
28%
Age at Diagnosis
28%
Prostate-specific Antigen Testing
25%
Tumor
25%
Colorectal Cancer Patients
24%
185delAG
24%
MLH1
23%
MSH2
22%
Cancer Diagnosis
21%
Mismatch Repair
20%
Mismatch Repair Genes
20%
Israeli Jews
19%
Founder Pathogenic Variant
19%
Cancer Screening Program
19%
Early Onset
19%
Sporadic Cases
19%
Germline mutation
19%
Colon Cancer
18%
Iraqi Jews
18%
Diagnostic Performance
17%
MSH6
16%
Biochemistry, Genetics and Molecular Biology
Cancer Screening
99%
BRCA1
92%
Prostate-Specific Antigen
87%
BRCA2
74%
Germ Cell
60%
Germline
60%
Penetrance
46%
MSH2
40%
DNA Mismatch Repair
38%
Genetics
38%
Genetic Predisposition
37%
MLH1
36%
Germline Mutation
27%
Colon
27%
Missense Mutation
27%
Gel Electrophoresis
27%
Cancer Incidence
27%
Screening
22%
MSH6
22%
Gene Repair
21%
Cohort Study
19%
Prevalence
19%
Whole Genome Sequencing
16%
Gene Sequence
16%
Steroid Sulfatase
16%
Founder Effect
16%
Trisomy 21
16%
Alpha Fetoprotein Blood Level
16%
Prospective Study
16%
Y Chromosome
16%
Chromosome 15
16%
2,5-Dimethoxy-4-iodoamphetamine
16%
Human Chorionic Gonadotropin
16%
DNA Flanking Region
16%
Nucleic Acid Hybridization
16%
Pregnancy
16%
Fluorescence in Situ Hybridization
16%
Haplotype
16%
Polymerase Chain Reaction
16%
Tumor Gene
16%
Population
14%
Alpha-Fetoprotein
11%
Microsatellite Instability
10%
Karyotype
10%
PMS2
10%
Genetic Screening
8%
Oncogene Ras
8%
P53
8%
Suxamethonium Chloride
8%
Cadherin
8%
Medicine and Dentistry
Prostate Cancer
90%
Cancer Screening
83%
BRCA1
70%
Prostate Specific Antigen
68%
Malignant Neoplasm
51%
BRCA2
48%
Breast Cancer
35%
Genetic Predisposition
33%
Germ Cell
25%
Cancer Incidence
24%
Antigen
24%
DNA Mismatch Repair
22%
Screening
19%
BRCA Mutation
19%
Ovarian Cancer
19%
Hereditary Nonpolyposis Colorectal Cancer
17%
Uterine Cancer
17%
Colorectal Carcinoma
17%
Penetrance
16%
4 Iodo 2,5 Dimethoxyamphetamine
16%
Observational Study
16%
Retrospective Cohort Study
16%
Gene Repair
16%
Prospective Study
16%
Pancreas Cancer
16%
Tumor Gene
16%
Cancer Risk
13%
Pancreas Adenocarcinoma
13%
Neoplasm
12%
Biopsy Technique
12%
Cancer Diagnosis
9%
Impact of Events Scale
8%
Diseases
7%
Family History
6%
Risk Perception
6%
Short Form 36
6%
Salpingooophorectomy
5%
Neuroendocrine Tumor
5%
Precursor
5%
Connective Tissue Cancer
5%
Prostate Biopsy
5%
